Morphogens and growth factor signalling in the myeloma bone-lining niche
Multiple myeloma is a malignancy caused by the clonal expansion of abnormal plasma cells. Myeloma cells have proven to be incredibly successful at manipulating their microenvironment to promote growth and to evade modern therapies. They have evolved to utilise the integral signalling pathways of the...
Auteurs principaux: | Morris, EV, Edwards, CM |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Springer
2021
|
Documents similaires
-
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
par: Gooding, S, et autres
Publié: (2019) -
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease
par: Sarah Gooding, et autres
Publié: (2019-10-01) -
PB2082: BONE MORPHOGENIC PROTEIN-6 PROMOTES THE PROLIFERATION AND INHIBITS APOPTOSIS IN MULTIPLE MYELOMA
par: Jiaqi Fu, et autres
Publié: (2023-08-01) -
Myeloma and marrow adiposity: Unanswered questions and future directions
par: Morris, EV, et autres
Publié: (2021) -
The antidiabetic drug metformin acts on the bone microenvironment to promote myeloma cell adhesion to preosteoblasts and increase myeloma tumour burden in vivo
par: Gámez, B, et autres
Publié: (2021)